Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

POSTMARKETING OBSERVATIONAL STUDY OF THE IMPACT OF PREVNAR 13 (PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE) ON OTITIS MEDIA IN CHILDREN

NCT01272999 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01272999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01272999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
POSTMARKETING OBSERVATIONAL STUDY OF THE IMPACT OF PREVNAR 13 (PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE) ON OTITIS MEDIA IN CHILDREN
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
May 21, 2010
Completion date
December 19, 2013
Enrollment
391 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute otitis media, mastoiditis